Healthcare provider profile · identity verified

Elena Aminov

Nurse Practitioner · PHOENIX, AZ · NPI 1992301923

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	321	124
Gabapentin	Gabapentin	236	76
Lisinopril	Lisinopril	217	70
Amlodipine Besylate	Amlodipine Besylate	195	65
Albuterol Sulfate Hfa	Albuterol Sulfate	182	82
Losartan Potassium	Losartan Potassium	179	67
Meloxicam	Meloxicam	171	60
Levothyroxine Sodium	Levothyroxine Sodium	166	50
Furosemide	Furosemide	152	48
Prednisone	Prednisone	144	88
Tamsulosin Hcl	Tamsulosin Hcl	140	57
Jardiance	Empagliflozin	138	40
Montelukast Sodium	Montelukast Sodium	132	67
Trazodone Hcl	Trazodone Hcl	132	36
Metformin Hcl	Metformin Hcl	112	39
Omeprazole	Omeprazole	100	40
Pantoprazole Sodium	Pantoprazole Sodium	100	39
Carvedilol	Carvedilol	99	31
Famotidine	Famotidine	99	32
Rosuvastatin Calcium	Rosuvastatin Calcium	97	42
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	90	40
Duloxetine Hcl	Duloxetine Hcl	90	27
Methocarbamol	Methocarbamol	89	44
Hydroxyzine Hcl	Hydroxyzine Hcl	86	45
Metoprolol Tartrate	Metoprolol Tartrate	83	29
Oxycodone Hcl	Oxycodone Hcl	77	21
Ozempic	Semaglutide	76	19
Fluticasone Propionate	Fluticasone Propionate	72	38
Sertraline Hcl	Sertraline Hcl	72	28
Eliquis	Apixaban	65	19
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	63	23
Anoro Ellipta	Umeclidinium Brm/Vilanterol Tr	62	20
Clotrimazole-Betamethasone	Clotrimazole/Betamethasone Dip	62	32
Alendronate Sodium	Alendronate Sodium	61	27
Glipizide	Glipizide	59	19
Potassium Chloride	Potassium Chloride	58	23
Tramadol Hcl	Tramadol Hcl	58	25
Carbidopa-Levodopa	Carbidopa/Levodopa	57	23
Azithromycin	Azithromycin	56	52
Soliqua 100-33	Insulin Glargine/Lixisenatide	56	13
Mirtazapine	Mirtazapine	53	19
Spironolactone	Spironolactone	53	17
Amitriptyline Hcl	Amitriptyline Hcl	52	15
Hydrochlorothiazide	Hydrochlorothiazide	50	20
Triamcinolone Acetonide	Triamcinolone Acetonide	49	33
Hydralazine Hcl	Hydralazine Hcl	48	suppressed
Doxycycline Monohydrate	Doxycycline Monohydrate	47	34
Vitamin D2	Ergocalciferol (Vitamin D2)	47	18
Myrbetriq	Mirabegron	46	17
Sumatriptan Succinate	Sumatriptan Succinate	46	12
Metoprolol Succinate	Metoprolol Succinate	45	16
Metformin Hcl Er	Metformin Hcl	44	17
Clopidogrel	Clopidogrel Bisulfate	43	14
Warfarin Sodium	Warfarin Sodium	42	suppressed
Ondansetron Hcl	Ondansetron Hcl	41	15
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	40	14
Diclofenac Sodium	Diclofenac Sodium	37	26
Lactulose	Lactulose	37	15
Boostrix Tdap	Diphth,pertuss(Acell),tet Vac	35	35
Methylprednisolone	Methylprednisolone	33	27
Finasteride	Finasteride	30	12
Tizanidine Hcl	Tizanidine Hcl	30	12
Donepezil Hcl	Donepezil Hcl	27	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	27	13
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	27	21
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	27	suppressed
Ropinirole Hcl	Ropinirole Hcl	27	suppressed
Alprazolam	Alprazolam	26	suppressed
Ammonium Lactate	Ammonium Lactate	26	16
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	26	21
Ibuprofen	Ibuprofen	26	14
Lidocaine	Lidocaine	26	14
Linzess	Linaclotide	26	11
Propranolol Hcl	Propranolol Hcl	26	suppressed
Simvastatin	Simvastatin	26	suppressed
Trulicity	Dulaglutide	26	suppressed
Xarelto	Rivaroxaban	25	suppressed
Bumetanide	Bumetanide	23	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	23	suppressed
Allopurinol	Allopurinol	22	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	22	suppressed
Escitalopram Oxalate	Escitalopram Oxalate	21	suppressed
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	21	11
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	21	13
Baclofen	Baclofen	20	suppressed
Farxiga	Dapagliflozin Propanediol	20	suppressed
Sildenafil Citrate	Sildenafil Citrate	20	suppressed
Bupropion Xl	Bupropion Hcl	19	suppressed
Clonidine Hcl	Clonidine Hcl	19	suppressed
Fluconazole	Fluconazole	19	suppressed
Mounjaro	Tirzepatide	19	suppressed
Lagevrio (Eua)	Molnupiravir	18	17
Memantine Hcl	Memantine Hcl	18	suppressed
Pioglitazone Hcl	Pioglitazone Hcl	18	suppressed
Pravastatin Sodium	Pravastatin Sodium	18	suppressed
Advair Hfa	Fluticasone Propion/Salmeterol	17	suppressed
Ibu	Ibuprofen	17	suppressed
Klor-Con	Potassium Chloride	17	suppressed
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	17	suppressed
Sucralfate	Sucralfate	17	suppressed
Valsartan	Valsartan	17	suppressed
Celecoxib	Celecoxib	16	suppressed
Nifedipine Er	Nifedipine	16	suppressed
Paroxetine Hcl	Paroxetine Hcl	16	suppressed
Valacyclovir	Valacyclovir Hcl	16	suppressed
Bupropion Hcl	Bupropion Hcl	15	suppressed
Colchicine	Colchicine	15	suppressed
Entresto	Sacubitril/Valsartan	15	suppressed
Ezetimibe	Ezetimibe	15	suppressed
Ipratropium Bromide	Ipratropium Bromide	15	suppressed
Varenicline Tartrate	Varenicline Tartrate	15	suppressed
Estradiol	Estradiol	14	suppressed
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	14	suppressed
Wixela Inhub	Fluticasone Propion/Salmeterol	14	suppressed
Dextroamphetamine-Amphetamine	Dextroamphetamine/Amphetamine	13	suppressed
Folic Acid	Folic Acid	13	suppressed
Ondansetron Odt	Ondansetron	13	suppressed
Pregabalin	Pregabalin	13	suppressed
Fluoxetine Hcl	Fluoxetine Hcl	12	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	12	suppressed
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	12	suppressed
Synthroid	Levothyroxine Sodium	12	suppressed
Testosterone Cypionate	Testosterone Cypionate	12	suppressed
Clonazepam	Clonazepam	11	suppressed
Hydroxyzine Pamoate	Hydroxyzine Pamoate	11	suppressed
Roflumilast	Roflumilast	11	suppressed
Stiolto Respimat	Tiotropium Br/Olodaterol Hcl	11	suppressed
Temazepam	Temazepam	11	suppressed
Terbinafine Hcl	Terbinafine Hcl	11	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error